Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1999;34:398-402

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mannelli, M.
Right arrow Articles by Franchi, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mannelli, M.
Right arrow Articles by Franchi, F.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*DOPAMINE
Related Collections
Right arrow Hypertension - basic studies
Right arrow Exercise/exercise testing/rehabilitation
Right arrow Autonomic, reflex, and neurohumoral control of circulation

(Hypertension. 1999;34:398-402.)
© 1999 American Heart Association, Inc.


Scientific Contributions

In Vivo Evidence That Endogenous Dopamine Modulates Sympathetic Activity in Man

Massimo Mannelli; Lucia Ianni; Chiara Lazzeri; Walter Castellani; Cinzia Pupilli; Giorgio La Villa; Giuseppe Barletta; Mario Serio; Franco Franchi

From the Department of Clinical Pathophysiology, Endocrine Unit (M.M., L.I., C.P., M.S.), Respiratory Pathophysiology Unit (W.C.), and the Institute of Internal Medicine, Cardiovascular Unit (C.L., G.L.V., F.F.), University of Florence, and the Cardiovascular Ultrasound Unit (G.B.), Azienda Ospedaliera Careggi, Florence, Italy.

Correspondence to Massimo Mannelli, MD, Dept of Clinical Pathophysiology, Endocrine Unit, University of Florence, Viale Pieraccini 6, 50139 Florence, Italy. E-mail m.mannelli{at}dfc.unifi.it

Abstract—Dopamine receptors type 2 (D2)-like receptor blockers cause an increase in the norepinephrine response to intense physical exercise. However, during intense physical exercise, D2-like antagonists also cause an increase in the epinephrine response, which itself might cause an increase in plasma norepinephrine through the activation of ß2 presynaptic receptors. Therefore, we evaluated the effect of domperidone, a D2-like antagonist, on the norepinephrine response to physical exercise in 6 Addison patients (3 were adrenalectomized and 3 had adrenal tuberculosis). In these patients, the norepinephrine increase observed during exercise was significantly higher after the administration of domperidone than a placebo (F=4,328; P<0.001). Because peripheral plasma norepinephrine does not reflect the sympathetic tone to the heart accurately, we evaluated the effect of domperidone administration (20 mg orally) on the sympathovagal balance, which was measured by the ratio between the high- and low-frequency components of heart rate variability, in 9 normal volunteers in the supine and sitting positions. When compared with placebo, domperidone caused a significant increase in the low/high frequency ratio (P<0.05) in the sitting position without modifying basal and stimulated norepinephrine plasma levels or blood pressure. These data support a role for endogenous dopamine in modulating norepinephrine release by human sympathetic nerves in vivo.


Key Words: dopamine • plasma • norepinephrine • heart




This article has been cited by other articles:


Home page
Pharmacol. Rev.Home page
S. Boehm and H. Kubista
Fine Tuning of Sympathetic Transmitter Release via Ionotropic and Metabotropic Presynaptic Receptors
Pharmacol. Rev., March 1, 2002; 54(1): 43 - 99.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
X. X. Li, M. Bek, L. D. Asico, Z. Yang, D. K. Grandy, D. S. Goldstein, M. Rubinstein, G. M. Eisner, and P. A. Jose
Adrenergic and Endothelin B Receptor-Dependent Hypertension in Dopamine Receptor Type-2 Knockout Mice
Hypertension, September 1, 2001; 38(3): 303 - 308.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
F. Franchi, C. Lazzeri, G. Barletta, L. Ianni, and M. Mannelli
Centrally Mediated Effects of Bromocriptine on Cardiac Sympathovagal Balance
Hypertension, July 1, 2001; 38(1): 123 - 129.
[Abstract] [Full Text] [PDF]